A Randomized Controlled Trial of Cognitive-Behavior Therapy Plus Bright Light Therapy for Adolescent Delayed Sleep Phase Disorder

This study investigated the effectiveness of a combined treatment for adolescents diagnosed with Delayed Sleep Phase Disorder (DSPD). The intervention consisted of two main components:

1. **Cognitive-Behavior Therapy (CBT):** This involved six individual therapy sessions designed to address aspects of insomnia and poor sleep hygiene often associated with DSPD. Key elements included cognitive restructuring (challenging unhelpful thoughts about sleep) and sleep education (providing knowledge about healthy sleep practices).

2. **Bright Light Therapy (BLT):** This component was specifically aimed at advancing the adolescents' circadian rhythms, which are naturally delayed in DSPD. While the abstract doesn't specify the exact light intensity or duration, it indicates morning application.

The combined CBT plus BLT was compared against a **waitlist (WL) control group**. Participants in the waitlist group received no active treatment during the initial study period but were offered the intervention after the post-treatment assessment.

The primary goal was to see if the combined therapy could help adolescents with DSPD shift their sleep schedules earlier and improve their sleep quality and daytime functioning.

The outcome measures used to assess the effectiveness of the intervention included:

**DSPD diagnosis:** Determined through a clinical interview and a 7-day sleep diary. This was a key diagnostic outcome.

**Sleep parameters:** Measured via online sleep diaries, including:

* Sleep latency (how long it takes to fall asleep)

* Sleep onset time (when sleep begins)

* Rise time (when waking occurs)

* Total sleep time (specifically on school nights)

* Wake after sleep onset (WASO, time spent awake during the night after initially falling asleep)

**Daytime impairments:** Measured using various scales for:

* Sleepiness

* Fatigue

* Depression symptoms

The study included **49 adolescents** who had been clinically diagnosed with Delayed Sleep Phase Disorder (DSPD).

**Mean age:** 14.6 years, with a standard deviation of 1.0 year (meaning most participants were between 13.6 and 15.6 years old).

**Gender:** 53% were males.

**Chronicity of DSPD:** On average, participants had been experiencing DSPD symptoms for 4 years and 8 months, indicating a long-standing issue for many.

**School attendance:** 16% of the adolescents were not attending school, which highlights the significant impact DSPD can have on daily functioning and education.

**Setting:** The study was conducted at the Flinders University Child & Adolescent Sleep Clinic in Adelaide, South Australia, suggesting a specialized clinical environment.

**Dropout rate:** 18% of the adolescents dropped out of the study before completion. Specifically, 23 participants remained in the CBT plus BLT group and 17 in the waitlist group for post-treatment assessment, implying 6 dropouts from the CBT+BLT group (initial N=29) and 3 from the WL group (initial N=20).

The researchers used a combination of clinical assessment and self-report tools to diagnose DSPD and measure treatment outcomes.

**DSPD Diagnosis:**

* **Clinical Interview:** A structured discussion with a clinician to gather detailed information about the individual's sleep patterns, history, and symptoms consistent with DSPD.

* **7-day Sleep Diary:** Participants kept a daily record of their sleep and wake times for a week. This provides objective, real-world data on sleep patterns, including sleep onset, wake times, and any awakenings during the night, which is crucial for diagnosing and monitoring DSPD.

**Treatment Outcome Measures (at pre-treatment, post-treatment, and 6-month follow-up):**

* **Online Sleep Diaries:** Similar to the diagnostic sleep diary but completed online, these were used to track specific sleep parameters throughout the study. This method allows for consistent, daily data collection on:

* **Sleep latency:** The time it takes from getting into bed with the intention to sleep until actually falling asleep.

* **Sleep onset time:** The actual clock time when sleep began.

* **Rise time:** The actual clock time when waking occurred.

* **Total sleep time (school nights):** The total duration of sleep obtained on nights preceding school days, a critical measure given the impact of DSPD on academic performance.

* **Wake after sleep onset (WASO):** The total time spent awake during the night after the initial sleep onset but before the final morning awakening.

* **Scales measuring sleepiness:** These are typically standardized questionnaires that assess subjective feelings of drowsiness and the propensity to fall asleep during the day. Examples include the Epworth Sleepiness Scale, though the specific scale isn't named in the abstract.

* **Scales measuring fatigue:** These questionnaires evaluate the subjective experience of tiredness, lack of energy, and exhaustion, which are common daytime consequences of DSPD.

* **Scales measuring depression symptoms:** Given the known comorbidity between sleep disorders and mood disorders, these scales assess the presence and severity of depressive symptoms.

The use of online sleep diaries provides a practical and consistent way to collect daily sleep data, offering a more detailed picture than single-point questionnaires. While subjective, sleep diaries are considered a gold standard for assessing sleep patterns in natural environments and are often used in conjunction with objective measures like actigraphy (though actigraphy was not mentioned in this abstract).

This study employed a **Randomized Controlled Trial (RCT)** design, which is considered the gold standard for evaluating the effectiveness of interventions.

**How they ran the study:**

1. **Participant Recruitment and Diagnosis:** 49 adolescents with a clinical diagnosis of Delayed Sleep Phase Disorder (DSPD) were recruited. The diagnosis was confirmed through a clinical interview and a 7-day sleep diary.

2. **Randomization:** After diagnosis, participants were randomly assigned to one of two groups:

* **CBT plus BLT group:** Received the active intervention.

* **Waitlist (WL) control group:** Received no active treatment during the initial study period.

* **Why randomisation matters:** Randomization is crucial because it helps ensure that, on average, the two groups are similar in all characteristics (known and unknown) at the start of the study. This minimizes the risk that any observed differences in outcomes between the groups are due to pre-existing differences rather than the intervention itself. For example, if one group happened to have more severe DSPD or more motivated participants by chance, this could bias the results. Randomization helps distribute these factors evenly.

3. **Intervention Delivery:**

* The CBT plus BLT group received 6 individual therapy sessions. These sessions included cognitive restructuring and sleep education components, along with instructions for morning bright light therapy. The individual nature of the sessions allowed for tailored guidance and support.

* The waitlist control group received no specific intervention during this initial phase. They were essentially "on hold" and served as a baseline for comparison.

4. **Assessments:** Measurements were taken at two key time-points for both groups:

* **Pre-treatment:** Before any intervention began, to establish baseline levels for all outcome measures.

* **Post-treatment:** After the CBT plus BLT group completed their 6 sessions, to assess immediate treatment effects.

* **Follow-up:** Only the CBT plus BLT group was assessed again at 6 months post-treatment. This was to evaluate the long-term maintenance of the treatment effects.

5. **Data Collection:** Online sleep diaries and various scales (for sleepiness, fatigue, depression symptoms) were used at each assessment point.

6. **Statistical Approach:** The study compared the changes in outcome measures from pre- to post-treatment between the CBT plus BLT group and the waitlist control group. Effect sizes (Cohen's d) were calculated to quantify the magnitude of the differences, and p-values were used to determine statistical significance.

**What this design can and cannot prove:**

**What it can prove:**

* **Causality:** As an RCT, this study can strongly suggest a causal link between the combined CBT plus BLT intervention and the observed improvements in sleep parameters and daytime functioning. Because participants were randomly assigned, it's highly probable that the intervention, rather than other confounding factors, was responsible for the changes.

* **Effectiveness of the combined intervention:** The study demonstrates that the *combination* of CBT and BLT is effective for adolescent DSPD.

* **Immediate and sustained effects:** The post-treatment assessment shows immediate benefits, and the 6-month follow-up for the intervention group suggests that these benefits are largely maintained over time.

**What it cannot prove:**

* **Effectiveness of individual components:** The study cannot determine whether CBT alone, BLT alone, or specific elements within each therapy are responsible for the observed improvements. It's possible that one component is more critical than the other, or that they work synergistically. This is a common limitation of multi-component interventions.

* **Long-term maintenance compared to control:** While the CBT plus BLT group showed sustained improvements at 6 months, there was no concurrent waitlist control group at this follow-up. Therefore, we cannot definitively say that the improvements at 6 months were *better than what would have happened naturally* or in a control group over that same period. The improvements might have been even greater compared to a continued waitlist, or perhaps some natural improvement would have occurred anyway.

* **Generalizability to other populations:** The study focused specifically on adolescents with DSPD. The findings may not directly apply to adults, younger children, or individuals with other sleep disorders.

**Major methodological weaknesses:**

**Lack of component analysis:** As noted, the study doesn't disentangle the effects of CBT versus BLT. This makes it difficult for future research or clinical practice to optimize treatment by identifying the most potent elements.

**No blinding of participants or therapists:** It's inherently difficult to blind participants to behavioral therapy or bright light therapy. Participants knew if they were receiving treatment, and therapists knew they were delivering it. This can introduce **performance bias** (participants might try harder or report better outcomes because they know they are receiving an active treatment) and **detection bias** (therapists might subtly influence outcomes or assessments). The waitlist control helps mitigate some of this, but it's still a factor.

**Follow-up only for the intervention group:** The absence of a control group at the 6-month follow-up limits the strength of conclusions about the long-term superiority of the intervention compared to no treatment.

**Dropout rate:** An 18% dropout rate is notable. If dropouts were not random (e.g., if those who weren't improving were more likely to drop out of the active treatment group), it could bias the results towards showing greater effectiveness. The abstract doesn't specify the reasons for dropout or if there were differential dropout rates between groups.

Despite these limitations, the RCT design with randomization